Kiromic Biopharma Inc. (KRBP) Social Stream

Featured Post From StockTwits About KRBP

$KRBP Kiromic achieved important scientific and operational milestones during the first half of the year that we believe have us well positioned for preparing our staff and our facilities for the first in-human dosing during the first quarter of 2022,” said Dr. Maurizio Chiriva-Internati, PhD, CEO and President of Kiromic BioPharma.

“We are thankful to our employees and collaborators who have maintained this high level of execution this year. From their efforts, we submitted two investigational new drug applications to the United States Food and Drug Administration in May 2021.”

Looks like another delay. Now stating Dosing the First Quarter 2022. A whole year wasted!!! Oh well. Gonna be a long term Hold.